This study is currently not recruiting participants.

CC100: Safety and Tolerability of Single Doses

  • STATUS
    Not Recruiting
Send
Updated on 19 February 2024

Summary

The primary objective of this study is to assess the safety and tolerability of ascending doses of orally administered CC100 in healthy subjects. The secondary objectives of the study are to determine pharmacokinetics and pharmacodynamics of CC100 in pla

Description

The primary objective of this study is to assess the safety and tolerability of ascending doses of orally administered CC100 in healthy subjects. The secondary objectives of the study are to determine pharmacokinetics and pharmacodynamics of CC100 in pla

Details
Condition Drug Safety
Age 100years or below
Clinical Study IdentifierTX3410
Last Modified on19 February 2024

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.